loading

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
15.92%
17.05
20.28 15.43 15.12 14.40
Operating Income/Loss
9.97%
-22.31
-24.78 -20.49 -20.28 -19.44
Nonoperating Income/Loss
4.88%
2.653
2.789 1.976 1.977 1.978
Income/Loss From Continuing Operations Before Tax
10.61%
-19.66
-21.99 -18.51 -18.30 -17.47
Income Tax Expense/Benefit
0.046
- - - -
Income/Loss From Continuing Operations After Tax
10.96%
-19.71
-22.13 -18.51 -18.30 -17.47
Net Income/Loss
10.96%
-19.71
-22.13 -18.51 -18.30 -17.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,849%
49.45
1.6769 38.19 37.86 37.78
Diluted Average Shares
2,849%
49.45
1.6769 38.19 37.86 37.78
Basic Earnings Per Share
20.00%
-0.40
-0.50 -0.48 -0.48 -0.46
Diluted Earnings Per Share
20.00%
-0.40
-0.50 -0.48 -0.48 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):